Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mustafa Çoban, Uğur Bilge, Hale Balseven, Hilmi Uysal & Betül Artut. (2023) The economic evaluation of ALS care: quality and cost. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 502-513.
Read now
Read now
James D. Berry, Marie Blanchard, Kerina Bonar, Emma Drane, Molly Murton, Uffe Ploug, Kristen Ricchetti-Masterson, Natasa Savic, Emma Worthington & Terry Heiman-Patterson. (2023) Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 436-448.
Read now
Read now
Toni Mora, Raúl Domínguez, Abdelilah Assialioui, Andrés Paipa, Ramon Moreno, Xavier Corbella, Antonio Martínez-Yelamos & Mònica Povedano. (2023) Direct health costs of amyotrophic lateral sclerosis in a multidisciplinary ALS unit in Catalonia (Spain). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:1-2, pages 133-138.
Read now
Read now
Giuseppe Fiorentino & Antonio M. Esquinas. (2018) Cost-effectiveness associated with amyotrophic lateral sclerosis: some questions and answers pending. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 315-316.
Read now
Read now
Articles from other publishers (11)
Eleanor Roberts. (2023) A Review of Oral Fixed-Dose Sodium Phenylbutyrate and Ursodoxicoltaurine in People with Amyotrophic Lateral Sclerosis. EMJ Neurology, pages 2-12.
Crossref
Crossref
Katie Stenson, Lasair O'Callaghan, Jennifer Mellor, Jack Wright, Gregor Gibson, Lucy Earl, Sophie Barlow & Christina Nicole Fournier. (2023) Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey. Journal of the Neurological Sciences 452, pages 120764.
Crossref
Crossref
Heather M. Young, Tina R. Kilaberia, Robin Whitney, Benjamin M. Link, Janice F. Bell, Orly Tonkikh, Jessica Famula & Björn Oskarsson. (2023)
Needs of persons living with
ALS
at home and their family caregivers: A scoping review
. Muscle & Nerve 68:3, pages 240-249.
Crossref
Crossref
Eleonora Volpato, Michele Vitacca, Luciana Ptacinsky, Agata Lax, Salvatore D’Ascenzo, Enrica Bertella, Mara Paneroni, Silvia Grilli & Paolo Banfi. (2022) Home-Based Adaptation to Night-Time Non-Invasive Ventilation in Patients with Amyotrophic Lateral Sclerosis: A Randomized Controlled Trial. Journal of Clinical Medicine 11:11, pages 3178.
Crossref
Crossref
K. Achtert & L. Kerkemeyer. (2021) The economic burden of amyotrophic lateral sclerosis: a systematic review. The European Journal of Health Economics 22:8, pages 1151-1166.
Crossref
Crossref
Benjamin Rix Brooks & Jerome E. Kurent. 2021. Public Policy in ALS/MND Care. Public Policy in ALS/MND Care
301
326
.
Nimish J. Thakore, Erik P. Pioro, Belinda L. Udeh, Brittany R. Lapin & Irene L. Katzan. (2020) A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole. Value in Health 23:12, pages 1543-1551.
Crossref
Crossref
Han SongJian-Chao Liu, Zi-Peng CaoWen-Jing LuoJing-Yuan Chen. (2020) Medical cost and healthcare utilization of amyotrophic lateral sclerosis in China. Medicine 99:47, pages e23258.
Crossref
Crossref
Jocelyn Zwicker, Danial Qureshi, Robert TalaricoPierre Bourque, Mary Scott, Nicolas Chin-Yee & Peter Tanuseputro. (2019) Dying of amyotrophic lateral sclerosis. Neurology 93:23.
Crossref
Crossref
Ileana Howard & Abigail Potts. (2019) Interprofessional Care for Neuromuscular Disease. Current Treatment Options in Neurology 21:8.
Crossref
Crossref
Helder Vieira, Nelson Costa, Tomás Sousa, Sara Reis & Luis Coelho. (2019) Voice-Based Classification of Amyotrophic Lateral Sclerosis: Where Are We and Where Are We Going? A Systematic Review. Neurodegenerative Diseases 19:5-6, pages 163-170.
Crossref
Crossref